Alarm raised over China’s threat to older Americans through drug supply chains
A US Senate hearing has raised alarms about China's influence over the American drug supply chain, particularly concerning its dominance in producing active pharmaceutical ingredients (APIs). Witnesses highlighted that China supplies a significant majority of US antibiotic APIs and a large portion of global API production. Concerns were also voiced about China's potential weaponization of these supply chains and the broader national security implications, including financial scams and data privacy threats targeting older Americans. AI
